Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05405426 · ClinicalTrials.gov registry record · NA
Trial of Indication-Based Transfusion of Red Blood Cells in ECMO
A NA study of Extracorporeal Membrane Oxygenation and Red Blood Cell Transfusion, sponsored by Boston Children's Hospital.
- Active
- Registry status
- NA
- Development phase
- 228
- Enrollment target
- 20
- Study locations
NCT05405426 is a NA study of Extracorporeal Membrane Oxygenation and Red Blood Cell Transfusion that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 228 participants, roughly in line with the 232-participant average among 5 other Extracorporeal Membrane Oxygenation trials with a reported enrollment target. The trial reports 20 study locations across 17 states.
The verdict
NCT05405426, a NA study of Extracorporeal Membrane Oxygenation and Red Blood Cell Transfusion, is active but no longer recruiting, sponsored by Boston Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
- 20
- Study locations
Study Summary
TITRE - Trial of Indication-based Transfusion of Red Blood Cells in ECMO, is a multicenter, prospective, randomized clinical trial. The overarching goal of TITRE is to determine whether restricting red blood cell (RBC) transfusion according to an indication-based strategy for those with bleeding and/or deficit of tissue oxygen delivery, compared with transfusion based on center-specific hemoglobin or hematocrit thresholds, can reduce organ dysfunction and improve later neurodevelopment in critically ill children receiving Extracorporeal Membrane Oxygenation (ECMO) support.
Conditions Studied
Interventions
- OTHER Red blood cell transfusion
Study Locations (20)
California
- Children's Hospital Los Angeles - Los Angeles
- Lucile Packard Children's Hospital - Palo Alto
Michigan
- University of Michigan Medical Center - Ann Arbor
- Children's Hospital of Michigan - Detroit
Texas
- Children's Health Dallas University of Texas Southwestern - Dallas
- Texas Children's Hospital - Baylor College of Medicine - Houston
Arizona
- Phoenix Children's Hospital - Phoenix
Arkansas
- Arkansas Children's Hospital - Little Rock
Colorado
- Children's Hospital Colorado - Aurora
Georgia
- Children's Healthcare of Atlanta - Atlanta
Illinois
- Lurie Children's Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2023-04-14 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05405426
The ClinicalTrials.gov registry entry for NCT05405426 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 232-participant average among 5 other Extracorporeal Membrane Oxygenation trials with a reported enrollment target. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Extracorporeal Membrane Oxygenation appearing as the primary indexed condition, and to 1 intervention - of which Red blood cell transfusion is the first listed.
NCT05405426 reports 20 study locations spanning 17 distinct geographic areas - top geographies include California, Michigan, Texas.
Frequently Asked Questions
What is clinical trial NCT05405426 about?
NCT05405426 is a clinical study titled "Trial of Indication-Based Transfusion of Red Blood Cells in ECMO". TITRE - Trial of Indication-based Transfusion of Red Blood Cells in ECMO, is a multicenter, prospective, randomized clinical trial. The overarching goal of TITRE is to determine whether restricting red blood cell (RBC) transfusion according to an indication-based strategy for those with bleeding and...
What is the current status of trial NCT05405426?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 228 participants. The study started on 2023-04-14. Estimated completion is 2026-12.
What conditions does trial NCT05405426 study?
This clinical trial studies the following conditions: Extracorporeal Membrane Oxygenation, Red Blood Cell Transfusion, Organ Failure, Multiple.
What interventions are being tested in trial NCT05405426?
The interventions under investigation include: Red blood cell transfusion (OTHER).
Who is sponsoring clinical trial NCT05405426?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05405426 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Extracorporeal Membrane Oxygenation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease
ACTIVE NOT RECRUITING · NA
-
The Effect of Prophylactic FFP Administration on ECMO Circuit Longevity
COMPLETED · NA
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
-
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
RECRUITING
-
Biomarkers of Brain Injury in Critically-Ill Children on Extracorporeal Membrane Oxygenation
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.